Function. This enzyme is a homodimeric glycoprotein that hydrolyses the terminal alpha-galactosyl moieties from glycolipids and glycoproteins. It predominantly ...
Welcome to Fabrazyme.com Fabry disease is an inherited disorder caused by the deficiency of an enzyme called alpha-galactosidase A or alpha-GAL.
Agalsidase beta is a man-made form of the naturally-occurring alpha-galactosidase A enzyme. A deficiency of this enzyme is called Fabry disease.
Fabrazyme® (agalsidase beta) is a recombinant human α-galactosidase A enzyme with the same amino acid sequence as the native enzyme. Purified agalsidase beta is a ...
Agalsidase beta is used to treat Fabry disease which is an inherited disease caused by the lack of an enzyme called alpha-galactosidase A, in the body.
What is agalsidase beta? Agalsidase beta is a man-made form of the naturally-occurring alpha-galactosidase A enzyme. A deficiency of this enzyme is called Fabry disease.
agalsidase beta Fabrazyme, Fibrazyme Pharmacologic class: Homodimeric glycoprotein Therapeutic class: Recombinant human alpha-galactosidase enzyme Pregnancy risk ...
genzyme Fabrazyme (agalsidase beta) Page 2 Pharmacokinetics Plasma profiles of Fabrazyme were studied at 0.3, 1.0 and 3.0 mg/kg in 15 patients with
Treating Fabry disease. Agalsidase beta is a glycoprotein. It works by providing the enzyme alpha-galactosidase A to the body. Do NOT use agalsidase beta if:
Fabrazyme (agalsidase beta) is supplied as a sterile, nonpyrogenic, white to off-white lyophilized cake or powder. Fabrazyme (agalsidase beta) 35 mg vials ...